Cure8 research brief
The study suggests a plant-derived extract can reduce inflammation and help restore the intestinal epithelial barrier in laboratory models of ulcerative colitis, which is directly relevant to research into new IBD treatments that target barrier repair and inflammatory signaling.
Researchers studying IBD mechanisms or new therapeutics, translational scientists interested in barrier function and signaling pathways, and clinicians following emerging preclinical research in ulcerative colitis.
The researchers tested STE in mice given 3% DSS to induce colitis and measured weight loss, colon length, disease activity index, histology, inflammatory cytokines (TNF-α, IL-6, IL-1β), and intestinal permeability.
In cell studies (HT-29), STE increased intracellular Ca2+, stimulated proliferation via ERK1/2 and p38 MAPK signaling, and upregulated tight junction proteins (ZO-1, occludin, claudin-1). STE also inhibited JAK2–STAT3 signaling under inflammatory conditions and restored transepithelial electrical resistance (TEER).
The authors propose STE acts through Ca-dependent ERK/p38 activation to promote regeneration while suppressing JAK-STAT–mediated junction disruption.
Results are from mouse and cell experiments reported in a Journal of Ethnopharmacology abstract; this is basic-science evidence and not clinical trial data. Safety, dosing, and efficacy in humans are unknown.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Researchers describe a natural peptide that binds IL‑17RA and reduced disease measures in mouse colitis models — a potential new mechanism for reducing gut inflammation and restoring the epithelial barrier that could...
This paper identifies a herbal formula that improved inflammation and epithelial barrier repair in a mouse colitis model and highlights specific molecular pathways (CAV1/FAK/paxillin and metabolite pathways) that might...
The study suggests a new mechanism—blocking HSP90-mediated necroptosis of intestinal epithelial cells—that may reduce inflammation and tissue damage in ulcerative colitis, which could guide early drug-discovery efforts.
